Intrum AB (publ) (LON:0H9P)
42.08
+0.39 (0.94%)
At close: Nov 7, 2025
Intrum AB Revenue
Intrum AB had revenue of 4.06B SEK in the quarter ending September 30, 2025, a decrease of -2.76%. This brings the company's revenue in the last twelve months to 17.36B, down -4.78% year-over-year. In the year 2024, Intrum AB had annual revenue of 18.03B with 1.85% growth.
Revenue (ttm)
17.36B SEK
Revenue Growth
-4.78%
P/S Ratio
0.33
Revenue / Employee
1.85M SEK
Employees
9,376
Market Cap
446.91M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.03B | 328.00M | 1.85% |
| Dec 31, 2023 | 17.71B | -1.43B | -7.45% |
| Dec 31, 2022 | 19.13B | 1.34B | 7.54% |
| Dec 31, 2021 | 17.79B | 941.00M | 5.59% |
| Dec 31, 2020 | 16.85B | 863.00M | 5.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |